An increasing prevalence of Musculoskeletal Pain, novel and emerging pipeline therapies, awareness of the disease, and giant pharmaceutical entrants like Eli Lilly and Company, Sun Pharma Global
/PRNewswire/ DelveInsight s Musculoskeletal Pain Market Insights report provides a thorough understanding of current treatment practices, emerging drugs,.
Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had clinical outcomes similar to those observed in the overall clinical trial population, according to results from the ARAMIS phase III clinical trial presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.
RESEARCH TRIANGLE PARK - Job openings across the U.S. climbed to a new high of 10.1 million in June, the Bureau of Labor Statistics reported last week. And